Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

SELL
$9.85 - $13.24 $908,623 - $1.22 Million
-92,246 Reduced 99.53%
434 $5,000
Q1 2023

Apr 13, 2023

BUY
$10.04 - $15.5 $916,260 - $1.41 Million
91,261 Added 6431.36%
92,680 $1 Million
Q4 2022

Jan 23, 2023

SELL
$10.65 - $14.84 $340 - $474
-32 Reduced 2.21%
1,419 $0
Q3 2022

Oct 26, 2022

BUY
$9.39 - $16.99 $13,624 - $24,652
1,451 New
1,451 $21,000
Q2 2022

Jul 25, 2022

SELL
$3.92 - $9.73 $3,132 - $7,774
-799 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$5.31 - $8.7 $493 - $809
-93 Reduced 10.43%
799 $5,000
Q4 2021

Jan 28, 2022

BUY
$7.51 - $10.81 $6,698 - $9,642
892 New
892 $7,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $585M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.